Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,060
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/freshpoint-issues-recall-due-improperly-declared-allergen-egg-chicken-salad-wedge-sandwichesPublished September 8, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 1,501–1,520 of 18,346 recalls

FDA Recall Completed Historical recordClass II

Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30

by Padagis US LLC

Reason
Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Published
March 5, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

V Chocolates, Inc

Product
Assorted Chocolate Caramels with kosher sea salt, Net Weight…
Reason
Small pieces of plastic broken tray in the product.
Published
March 5, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Nestle-USA, Inc. (Corporate Office)

Product
Gerber Snacks for Baby Soothe 'n' Chew TEETHING STICKS Banan…
Reason
Firm received complaints of infant choking.
Published
March 5, 2025
Distribution
The products were shipped to distributio…

View recall →

FDA Recall United States Terminated Historical recordClass I

Nestle-USA, Inc. (Corporate Office)

Product
Gerber Snacks for Baby Soothe 'n' Chew TEETHING STICKS Straw…
Reason
Firm received complaints of infant choking.
Published
March 5, 2025
Distribution
The products were shipped to distributio…

View recall →

FDA Recall Ongoing Historical recordClass I

Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.

by Alvogen, Inc

Reason
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-761-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-760-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-759-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-758-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-757-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-756-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-755-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-271-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-269-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-268-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-267-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-265-30.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Published
February 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supplied as a single unit), Dist. by: Provepharm, Inc., Collegeville, PA 19426

by Provepharm Inc.

Reason
Presence of Particulate Matter.
Published
February 26, 2025
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.